Abstract 2308: Biomarkers of acquired resistance to sotorasib (soto) plus panitumumab (pani) in chemorefractory KRAS G12C-mutated metastatic colorectal cancer (mCRC)
Year: 2023
Type: conference-abstract
Source: Cancer Research
Institutions: The University of Texas MD Anderson Cancer Center, National Cancer Center Hospital East, Memorial Sloan Kettering Cancer Center, Duke Medical Center, Duke Cancer Institute, Aichi Cancer Center, University of Pennsylvania, University of Chicago, University of California, Davis, Amgen (United States), City Of Hope National Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4379985011
